Ashwin N. Ananthakrishnan

45.2k total citations · 14 hit papers
498 papers, 22.5k citations indexed

About

Ashwin N. Ananthakrishnan is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Ashwin N. Ananthakrishnan has authored 498 papers receiving a total of 22.5k indexed citations (citations by other indexed papers that have themselves been cited), including 324 papers in Genetics, 300 papers in Epidemiology and 151 papers in Surgery. Recurrent topics in Ashwin N. Ananthakrishnan's work include Inflammatory Bowel Disease (316 papers), Microscopic Colitis (264 papers) and Eosinophilic Esophagitis (62 papers). Ashwin N. Ananthakrishnan is often cited by papers focused on Inflammatory Bowel Disease (316 papers), Microscopic Colitis (264 papers) and Eosinophilic Esophagitis (62 papers). Ashwin N. Ananthakrishnan collaborates with scholars based in United States, Canada and France. Ashwin N. Ananthakrishnan's co-authors include David G. Binion, Hamed Khalili, Emily L. McGinley, Andrew T. Chan, Kia Saeian, James M. Richter, Vijay Yajnik, Millie D. Long, Leslie M. Higuchi and Charles S. Fuchs and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Nature Medicine.

In The Last Decade

Ashwin N. Ananthakrishnan

469 papers receiving 22.1k citations

Hit Papers

Epidemiology and risk factors for IBD 2013 2026 2017 2021 2015 2013 2019 2017 2013 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Epidemiology and risk factors for IBD
    2015 1.3k citations Ashwin N. Ananthakrishnan profile →
  2. Guidelines for Diagnosis, Treatment, and Prevention of Clostridium difficile Infections
    2013 1.2k citations Ashwin N. Ananthakrishnan et al. The American Journal of Gastroenterology profile →
  3. ACG Clinical Guideline: Ulcerative Colitis in Adults
    2019 1.0k citations David T. Rubin, Ashwin N. Ananthakrishnan et al. The American Journal of Gastroenterology profile →
  4. Environmental triggers in IBD: a review of progress and evidence
    2017 662 citations Ashwin N. Ananthakrishnan et al. profile →
  5. A Prospective Study of Long-term Intake of Dietary Fiber and Risk of Crohn's Disease and Ulcerative Colitis
    2013 453 citations Ashwin N. Ananthakrishnan, Hamed Khalili et al. Gastroenterology profile →
  6. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease
    2013 380 citations Ashwin N. Ananthakrishnan, Hamed Khalili et al. profile →
  7. Gut Microbiome Function Predicts Response to Anti-integrin Biologic Therapy in Inflammatory Bowel Diseases
    2017 307 citations Ashwin N. Ananthakrishnan, Hamed Khalili et al. profile →
  8. Depression and anxiety in inflammatory bowel disease: epidemiology, mechanisms and treatment
    2022 302 citations Ashwin N. Ananthakrishnan et al. profile →
  9. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century
    2020 187 citations Ashwin N. Ananthakrishnan, Gilaad G. Kaplan et al. Clinical Gastroenterology and Hepatology profile →
  10. Gut microbial metabolism of 5-ASA diminishes its clinical efficacy in inflammatory bowel disease
    2023 95 citations Ashwin N. Ananthakrishnan, Andrew T. Chan et al. profile →
  11. The landscape of immune dysregulation in Crohn’s disease revealed through single-cell transcriptomic profiling in the ileum and colon
    2023 94 citations Ashwin N. Ananthakrishnan, Ramnik J. Xavier et al. profile →
  12. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Ulcerative Colitis
    2023 71 citations Siddharth Singh, Ashwin N. Ananthakrishnan et al. Gastroenterology profile →
  13. Food Processing and Risk of Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    2023 67 citations Ashwin N. Ananthakrishnan et al. Clinical Gastroenterology and Hepatology profile →
  14. Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities
    2025 42 citations Ashwin N. Ananthakrishnan et al. profile →

Peers

Ashwin N. Ananthakrishnan
Comparison fields: 5 of 180
  • Genetics 11.6k
  • Epidemiology 10.6k
  • Surgery 5.8k
  • Molecular Biology 4.4k
  • Infectious Diseases 3.7k
David T. Rubin United States
Gilaad G. Kaplan Canada
Subrata Ghosh United Kingdom
Richard N. Fedorak Canada
Eric I. Benchimol Canada
Siew C. Ng Hong Kong
Anne M. Griffiths Canada
Julián Panés Spain
Remo Panaccione Canada
Siddharth Singh United States
David T. Rubin United States View profile →
Citations per field, relative to Ashwin N. Ananthakrishnan
Ashwin N. Ananthakrishnan · 1×
Citations per year, relative to Ashwin N. Ananthakrishnan
Ashwin N. Ananthakrishnan · 1×

Countries citing papers authored by Ashwin N. Ananthakrishnan

Since Specialization
Citations

This map shows the geographic impact of Ashwin N. Ananthakrishnan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashwin N. Ananthakrishnan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashwin N. Ananthakrishnan more than expected).

Fields of papers citing papers by Ashwin N. Ananthakrishnan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashwin N. Ananthakrishnan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashwin N. Ananthakrishnan. The network helps show where Ashwin N. Ananthakrishnan may publish in the future.

Co-authorship network of co-authors of Ashwin N. Ananthakrishnan

This figure shows the co-authorship network connecting the top 25 collaborators of Ashwin N. Ananthakrishnan. A scholar is included among the top collaborators of Ashwin N. Ananthakrishnan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashwin N. Ananthakrishnan. Ashwin N. Ananthakrishnan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
Transcriptome Profiling and Viral−Human Interactome Insights Into HBV‐Driven Oncogenic Alterations in Hepatocellular Carcinoma
2025 ·Microbiology and Immunology ·Ashwin N. Ananthakrishnan, (unknown), Thottethodi Subrahmanya Keshava Prasad, Chandran S. Abhinand
1
2
Environmental risk factors of inflammatory bowel disease: toward a strategy of preventative health
2025 ·Journal of Crohn s and Colitis ·(unknown), Beatriz Gros, James A. King, Joseph W. Windsor, Julia Gorospe, Haim Leibovitzh, Mingyue Xue, Williams Turpin, Kenneth Croitoru, Ashwin N. Ananthakrishnan, Richard B. Gearry, Gilaad G. Kaplan
6
3
Vedolizumab Versus Other Biologics and the Risk of Venous Thromboembolism in Patients with Pediatric-Onset Inflammatory Bowel Diseases: A Target Trial Emulation Study
2025 ·Pediatric Drugs ·(unknown), Ashwin N. Ananthakrishnan, Harland S. Winter, Kevin Sheng‐Kai
0
4
Clinical outcomes in Crohn's disease patients with short bowel syndrome on home parenteral nutrition are comparable to those with short bowel syndrome from other etiologies
2025 ·Clinical Nutrition ·Alexa N. Sasson, Jessica Noelting, Katherine J. P. Schwenger, (unknown), David Armstrong, Maitreyi Raman, Donald R. Duerksen, Scott Whittaker, Yidan Lu, Brian Jurewitsch, Leah Gramlich, Ashwin N. Ananthakrishnan, Johane P. Allard
1
5
Risk of Common Neurological Disorders in Adult Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
2024 ·Inflammatory Bowel Diseases ·Mohammad Zamani, (unknown), Shaghayegh Alizadeh‐Tabari, Scott E. Kasner, Mitchell S.V. Elkind, Ashwin N. Ananthakrishnan, (unknown), David T. Rubin, Reza Malekzadeh
11
6
Comparative Efficacy of Advanced Therapies for Management of Moderate-to-Severe Ulcerative Colitis: 2024 American Gastroenterological Association Evidence Synthesis
2024 ·Gastroenterology ·Ashwin N. Ananthakrishnan, M. Hassan Murad, Frank I. Scott, Manasi Agrawal, John P. Haydek, Berkeley N. Limketkai, Edward V. Loftus, Siddharth Singh
18
7
Predicting Outcomes in Hospitalized Patients With Acute Severe Ulcerative Colitis in a Prospective Multicenter Cohort
2024 ·Inflammatory Bowel Diseases ·(unknown), Benjamin Cohen, (unknown), Maia Kayal, Millie D. Long, Ashwin N. Ananthakrishnan, Joanna Melia
2
8
Content Validity and Psychometric Evaluation of the Functional Assessment of Chronic Illness Therapy–Fatigue (FACIT–Fatigue) in Patients with Crohn’s Disease and Ulcerative Colitis
2023 ·PharmacoEconomics - Open ·Edward V. Loftus, Ashwin N. Ananthakrishnan, Wan‐Ju Lee, Yuri Sánchez González, (unknown), Kori Wallace, Wen Zhou, Leighann Litcher‐Kelly, (unknown), (unknown), Silvio Danese
8
9
Progression of Pediatric Crohn’s Disease Is Associated With Anti–Tumor Necrosis Factor Timing and Body Mass Index Z-Score Normalization
2023 ·Clinical Gastroenterology and Hepatology ·Duke Geem, David M. Hercules, (unknown), Suresh Venkateswaran, Anne M. Griffiths, Joshua D. Noe, Jennifer L. Dotson, Scott B. Snapper, Shervin Rabizadeh, Joel R. Rosh, Robert N. Baldassano, James Markowitz, Thomas D. Walters, Ashwin N. Ananthakrishnan, (unknown), Lee A. Denson, Jeffrey S. Hyams, Subra Kugathasan
9
10
Mild Crohn’s Disease: Definition and Management
2023 ·Current Gastroenterology Reports ·(unknown), (unknown), Ashwin N. Ananthakrishnan, Jean‐Frédéric Colombel, Manasi Agrawal, Ryan C. Ungaro
15
11
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel
2022 ·The American Journal of Gastroenterology ·Parambir S. Dulai, Victoria Rai, Laura E. Raffals, Dana J. Lukin, David Hudesman, Gursimran Kochhar, Oriana M. Damas, Jenny Sauk, Alexander N. Levy, M. Anthony Sofia, Anne Tuskey, Parakkal Deepak, Andrés Yarur, Anita Afzali, Ashwin N. Ananthakrishnan, Raymond K. Cross, Stephen B. Hanauer, Corey A. Siegel
5
12
Incidence and Predictors of Flares in the Postpartum Year Among Women With Inflammatory Bowel Disease
2020 ·Inflammatory Bowel Diseases ·(unknown), Sonia Friedman, Ashwin N. Ananthakrishnan
28
13
Disease and Treatment Patterns Among Patients With Pouch-related Conditions in a Cohort of Large Tertiary Care Inflammatory Bowel Disease Centers in the United States
2020 ·Crohn s & Colitis 360 ·Edward L. Barnes, Laura H. Raffals, Millie D. Long, Gaurav Syal, Maia Kayal, Ashwin N. Ananthakrishnan, Benjamin L. Cohen, Joel Pekow, Parakkal Deepak, Jean‐Frédéric Colombel, Hans Herfarth, Robert S. Sandler
8
14
The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response
2019 ·eLife ·Sydney Lavoie, Kara L. Conway, Kara G. Lassen, Humberto Jijon, Hui Pan, Eunyoung Chun, Monia Michaud, Jessica Lang, (unknown), Jonathan M. Dreyfuss, Jonathan N. Glickman, Hera Vlamakis, Ashwin N. Ananthakrishnan, Aleksandar D. Kostic, Wendy S. Garrett, Ramnik J. Xavier
98
15
Effect of Accelerated Infliximab Induction on Short- and Long-term Outcomes of Acute Severe Ulcerative Colitis: A Retrospective Multicenter Study and Meta-analysis
2018 ·Clinical Gastroenterology and Hepatology ·(unknown), (unknown), Gloria Tran, Nienke Z. Borren, Danny J. Avalos, Jay Luther, Francis Colizzo, John J. Garber, Hamed Khalili, Joanna Melia, Matthew Bohm, Ashwin N. Ananthakrishnan
64
16
Systematic review with meta‐analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn's disease and ulcerative colitis controlled trials
2017 ·Alimentary Pharmacology & Therapeutics ·Aurada Cholapranee, Glen Hazlewood, Gilaad G. Kaplan, Laurent Peyrin‐Biroulet, Ashwin N. Ananthakrishnan
221
17
Systematic review with meta‐analysis: enteral nutrition therapy for the induction of remission in paediatric Crohn's disease
2017 ·Alimentary Pharmacology & Therapeutics ·Arun Swaminath, (unknown), Ashwin N. Ananthakrishnan, Louise Falzon, Susan Ferry
111
18
Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study
2016 ·Cancer Prevention Research ·Mingyang Song, Gauree G. Konijeti, Chen Yuan, Ashwin N. Ananthakrishnan, Shuji Ogino, Charles S. Fuchs, Edward L. Giovannucci, Kimmie Ng, Andrew T. Chan
32
19
Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases
2015 ·Inflammatory Bowel Diseases ·Ashwin N. Ananthakrishnan, Andrew Cagan, Tianxi Cai, Vivian S. Gainer, Stanley Y. Shaw, Susanne Churchill, Elizabeth W. Karlson, Shawn N. Murphy, Isaac S. Kohane, Katherine P. Liao, Ramnik J. Xavier
27
20
The association between low density lipoprotein (LDL) and RA genetic factors with LDL levels in rheumatoid arthritis and non-RA controls
2013 ·PubMed Central ·Katherine P. Liao, Dorothée Diogo, Jing Cui, Tianxi Cai, Yukinori Okada, Vivian S. Gainer, Shawn N. Murphy, Namrata Gupta, Daniel B. Mirel, Ashwin N. Ananthakrishnan, Peter Szolovits, Stanley Y. Shaw, Soumya Raychaudhuri, Susanne Churchill, Isaac S. Kohane, Elizabeth W. Karlson, Robert M. Plenge
21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David T. Rubin Breakdown of academic impact, for papers by Gilaad G. Kaplan Breakdown of academic impact, for papers by Subrata Ghosh Breakdown of academic impact, for papers by Richard N. Fedorak Breakdown of academic impact, for papers by Eric I. Benchimol Breakdown of academic impact, for papers by Siew C. Ng Breakdown of academic impact, for papers by Anne M. Griffiths Breakdown of academic impact, for papers by Julián Panés Breakdown of academic impact, for papers by Remo Panaccione Breakdown of academic impact, for papers by Siddharth Singh
Rankless by CCL
2026